| Manogna Maddineni, MD | |
|
677 Church St Ne # 111, Marietta, GA 30060-1101 | |
| (770) 793-7750 | |
| Not Available |
| Full Name | Manogna Maddineni |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 23 Years |
| Location | 677 Church St Ne # 111, Marietta, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083827232 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 06549 (Georgia) | Primary |
| 207R00000X | Internal Medicine | 063369 (Georgia) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wellstar Douglas Hospital | Douglasville, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellstar Medical Group, Llc | 6709065402 | 1839 |
News Archive
This research, reported in this week's issue of Science, is part of a larger research initiative being led by Adolfo Garcia-Sastre, PhD, Professor of Microbiology and Peter Palese, PhD, Professor and Chairman of Microbiology at Mount Sinai School of Medicine.
Though two of the best-known methods for analyzing rare variants in sequencing data were published in 2008 and 2010, they have never been available to the public as a supported package.
Grifols, a global healthcare company and biopharmaceutical manufacturer based in Barcelona, Spain today announced that it received approval from the US Food and Drug Administration for revised labeling for Alphanate Antihemophilic Factor/von Willebrand Factor Complex indicating that certain manufacturing steps have been shown to reduce the infectivity of a experimental TSE agent that is a model for variant Creutzfeldt Jakob Disease.
What makes joints in people with rheumatoid arthritis, and related conditions like Lyme disease or lupus, so susceptible to attack by the body's immune system, leading to painful flare-ups and deterioration? The answer may surprise you.
From today, Elsevier, a global leader in research publishing and information analytics specializing in science and health, is making all its research and data content on its COVID-19 Information Center available to PubMed Central, the archive of biomedical and lifescience at the US. National Institutes of Health's National Library of Medicine, and other publicly funded repositories globally, such as the WHO COVID database, for as long as needed while the public health emergency is ongoing.
› Verified 3 days ago
| Entity Name | The Emory Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396798229 PECOS PAC ID: 8820901408 Enrollment ID: O20031110000503 |
News Archive
This research, reported in this week's issue of Science, is part of a larger research initiative being led by Adolfo Garcia-Sastre, PhD, Professor of Microbiology and Peter Palese, PhD, Professor and Chairman of Microbiology at Mount Sinai School of Medicine.
Though two of the best-known methods for analyzing rare variants in sequencing data were published in 2008 and 2010, they have never been available to the public as a supported package.
Grifols, a global healthcare company and biopharmaceutical manufacturer based in Barcelona, Spain today announced that it received approval from the US Food and Drug Administration for revised labeling for Alphanate Antihemophilic Factor/von Willebrand Factor Complex indicating that certain manufacturing steps have been shown to reduce the infectivity of a experimental TSE agent that is a model for variant Creutzfeldt Jakob Disease.
What makes joints in people with rheumatoid arthritis, and related conditions like Lyme disease or lupus, so susceptible to attack by the body's immune system, leading to painful flare-ups and deterioration? The answer may surprise you.
From today, Elsevier, a global leader in research publishing and information analytics specializing in science and health, is making all its research and data content on its COVID-19 Information Center available to PubMed Central, the archive of biomedical and lifescience at the US. National Institutes of Health's National Library of Medicine, and other publicly funded repositories globally, such as the WHO COVID database, for as long as needed while the public health emergency is ongoing.
› Verified 3 days ago
| Entity Name | Wellstar Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558664003 PECOS PAC ID: 6709065402 Enrollment ID: O20110127000374 |
News Archive
This research, reported in this week's issue of Science, is part of a larger research initiative being led by Adolfo Garcia-Sastre, PhD, Professor of Microbiology and Peter Palese, PhD, Professor and Chairman of Microbiology at Mount Sinai School of Medicine.
Though two of the best-known methods for analyzing rare variants in sequencing data were published in 2008 and 2010, they have never been available to the public as a supported package.
Grifols, a global healthcare company and biopharmaceutical manufacturer based in Barcelona, Spain today announced that it received approval from the US Food and Drug Administration for revised labeling for Alphanate Antihemophilic Factor/von Willebrand Factor Complex indicating that certain manufacturing steps have been shown to reduce the infectivity of a experimental TSE agent that is a model for variant Creutzfeldt Jakob Disease.
What makes joints in people with rheumatoid arthritis, and related conditions like Lyme disease or lupus, so susceptible to attack by the body's immune system, leading to painful flare-ups and deterioration? The answer may surprise you.
From today, Elsevier, a global leader in research publishing and information analytics specializing in science and health, is making all its research and data content on its COVID-19 Information Center available to PubMed Central, the archive of biomedical and lifescience at the US. National Institutes of Health's National Library of Medicine, and other publicly funded repositories globally, such as the WHO COVID database, for as long as needed while the public health emergency is ongoing.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Manogna Maddineni, MD 8954 Hospital Drive, Douglasville, GA 30134 Ph: (678) 838-2585 | Manogna Maddineni, MD 677 Church St Ne # 111, Marietta, GA 30060-1101 Ph: (770) 793-7750 |
News Archive
This research, reported in this week's issue of Science, is part of a larger research initiative being led by Adolfo Garcia-Sastre, PhD, Professor of Microbiology and Peter Palese, PhD, Professor and Chairman of Microbiology at Mount Sinai School of Medicine.
Though two of the best-known methods for analyzing rare variants in sequencing data were published in 2008 and 2010, they have never been available to the public as a supported package.
Grifols, a global healthcare company and biopharmaceutical manufacturer based in Barcelona, Spain today announced that it received approval from the US Food and Drug Administration for revised labeling for Alphanate Antihemophilic Factor/von Willebrand Factor Complex indicating that certain manufacturing steps have been shown to reduce the infectivity of a experimental TSE agent that is a model for variant Creutzfeldt Jakob Disease.
What makes joints in people with rheumatoid arthritis, and related conditions like Lyme disease or lupus, so susceptible to attack by the body's immune system, leading to painful flare-ups and deterioration? The answer may surprise you.
From today, Elsevier, a global leader in research publishing and information analytics specializing in science and health, is making all its research and data content on its COVID-19 Information Center available to PubMed Central, the archive of biomedical and lifescience at the US. National Institutes of Health's National Library of Medicine, and other publicly funded repositories globally, such as the WHO COVID database, for as long as needed while the public health emergency is ongoing.
› Verified 3 days ago
Dr. Vaishali S Shah, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 677 Church St Ne, Attn: Hospitalist Office, Wellstar Kennestone Hospital, Marietta, GA 30060 Phone: 770-793-7750 Fax: 770-793-7755 | |
Bristol Yates Savage, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 677 Church St Ne # 111, Marietta, GA 30060 Phone: 770-793-7750 | |
Dr. Anila Jacob, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 677 Church Street, Wellstar Hospitalist Group-wellstar Kennestone Hospital, Marietta, GA 30060 Phone: 770-793-7750 | |
Zhaneta Dzmitryieva, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 677 Church St Ne, Marietta, GA 30060 Phone: 770-793-7750 Fax: 770-793-7755 | |
Christy Nelson, FNP Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 310 Kennestone Hospital Blvd, Marietta, GA 30060 Phone: 877-354-1821 | |
Kumiko Owada, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 677 Church St Ne, Marietta, GA 30060 Phone: 770-793-5000 |